Haemophilus B and hepatitis B vaccine

From Wikipedia, the free encyclopedia

Haemophilus B and hepatitis B vaccine
Combination of
Hib vaccineVaccine
Hepatitis B vaccineVaccine
Clinical data
Trade namesComvax
AHFS/Drugs.comMicromedex Detailed Consumer Information
Routes of
ATC code
CAS Number
  • none

Haemophilus B and hepatitis B vaccine is a combination vaccine whose generic name is Haemophilus b conjugate and hepatitis B recombinant vaccine.[1][2] It protects against the infectious diseases Haemophilus influenzae type B and hepatitis B.[2]

A branded formulation, Comvax, was marketed in the US by Merck.[3][4] It was discontinued in 2014.[5]


  1. ^ "Comvax". Drugs.com. Retrieved 15 July 2018.
  2. ^ a b "Haemophilus b conjugate and hepatitis b vaccine Intramuscular Advanced Patient Information". Drugs.com. 14 February 2020. Retrieved 13 September 2020.
  3. ^ Centers for Disease Control and Prevention (February 1997). "FDA approval for infants of a Haemophilus influenzae type b conjugate and hepatitis B (recombinant) combined vaccine" (PDF). MMWR Morb. Mortal. Wkly. Rep. 46 (5): 107–9. PMID 9045037.
  4. ^ "Comvax package insert" (PDF). Retrieved 15 July 2018.
  5. ^ Zarei AE, Almehdar HA, Redwan EM (2016). "Hib Vaccines: Past, Present, and Future Perspectives". Journal of Immunology Research. 2016: 7203587. doi:10.1155/2016/7203587. PMC 4745871. PMID 26904695.